Activin mediated endothelial dysfunction: novel therapies for preeclampsia

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1029148

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Preeclampsia remains a major cause of death of both pregnant women and their babies. The treatment for preeclampsia has not changed in decades. New insights into underlying causes of the disease have offered opportunities for the development of better, more effective treatments. This project aims to test such new therapies in an animal model of the disease with a view to future clinical trials.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $601,582.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Obstetrics and Gynaecology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

activin and inhibin | endothelial dysfunction | hypertension | maternal health | mouse models | oxidative stress | pre-eclampsia | pregnancy complications

Related Links